Nuvectis Pharma, Inc.NVCTNASDAQ
Loading
Cash Flow PerformanceNormalizing
Percentile Rank80
Studio
Year-over-Year Change

Free cash flow yield

Latest
-9.72%
↑ 20% vs avg
Percentile
P80
Within normal range
Streak
1 yr
Consecutive growthNormalizing
Average
-12.09%
Historical baseline
PeriodValueYoY Change
2025-9.72%+26.5%
2024-13.23%-7.6%
2023-12.30%+13.9%
2022-14.28%+37.9%
2021-22.99%-
20200.00%-